• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

兽医会对感染新型冠状病毒(SARS-CoV-2)具有免疫力吗?

Could veterinarians be immune to contracting SARS-CoV-2?

作者信息

Kozłowska-Geller Monika Anna, Lewitowicz Piotr, Węgierek-Ciuk Aneta, Białek Wioletta Adamus, Piechowska Agnieszka, Głuszek Stanisław Zbigniew

机构信息

Jan Kochanowski University of Kielce, Poland.

出版信息

Cent Eur J Immunol. 2022;47(3):275-279. doi: 10.5114/ceji.2022.119893. Epub 2022 Oct 4.

DOI:10.5114/ceji.2022.119893
PMID:36817264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9896990/
Abstract

INTRODUCTION

The aim of the study was to assess the epidemic situation among veterinarians of the Świętokrzyskie Voivodeship, Poland, in relation to the control group.

MATERIAL AND METHODS

The research was divided into 3 stages. Stage I involved the selection of subjects. In stage II, flow cytometry for immunophenotyping was performed and the percentage of the sub-population of CD4 cells and CD8 cells was assessed. Stage III involved collection of nasopharyngeal swab samples in order to determine the canine coronavirus CR-CoV mRNA with the rT-PCR method.

RESULTS

The percentage of the CD4 and CD8 lymphocyte subpopulation in relation to the total lymphocyte population in veterinarians did not differ statistically from the percentage in the control group. The CD4/CD8 ratio in the group of veterinarians was on average 1.93, and 2.04 in the control group. There was no statistically significant difference between the groups, p = 0.591. Canine CR-CoV mRNA was not detected in any of the veterinarians or in the control group.

CONCLUSIONS

None of the veterinarians had a significant increase in T lymphocytes, which could be an effective defense against SARS-CoV-2.

摘要

引言

本研究的目的是评估波兰什切青省兽医群体相对于对照组的疫情情况。

材料与方法

研究分为三个阶段。第一阶段涉及研究对象的选择。在第二阶段,进行免疫表型分析的流式细胞术,并评估CD4细胞和CD8细胞亚群的百分比。第三阶段涉及采集鼻咽拭子样本,以便用逆转录聚合酶链反应(rT-PCR)方法检测犬冠状病毒CR-CoV的信使核糖核酸(mRNA)。

结果

兽医群体中CD4和CD8淋巴细胞亚群相对于总淋巴细胞群体的百分比与对照组相比,在统计学上没有差异。兽医组的CD4/CD8比值平均为1.93,对照组为2.04。两组之间没有统计学上的显著差异,p = 0.591。在任何兽医或对照组中均未检测到犬CR-CoV mRNA。

结论

没有一名兽医的T淋巴细胞有显著增加,而T淋巴细胞可能是对抗严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的有效防御。

相似文献

1
Could veterinarians be immune to contracting SARS-CoV-2?兽医会对感染新型冠状病毒(SARS-CoV-2)具有免疫力吗?
Cent Eur J Immunol. 2022;47(3):275-279. doi: 10.5114/ceji.2022.119893. Epub 2022 Oct 4.
2
Evaluation of the Levels of Peripheral CD3, CD4, and CD8 T Cells and IgG and IgM Antibodies in COVID-19 Patients at Different Stages of Infection.评价不同感染阶段 COVID-19 患者外周血 CD3、CD4、CD8 T 细胞及 IgG、IgM 抗体水平。
Microbiol Spectr. 2022 Feb 23;10(1):e0084521. doi: 10.1128/spectrum.00845-21.
3
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.SARS-CoV-2 依维莫司纳瓦拉-ISGlobal 试验(SAINT)评估依维莫司在症状出现后 48 小时内降低低危、非重症 COVID-19 患者 COVID-19 传播风险的潜力:一项随机对照试验方案的研究方案结构化总结。
Trials. 2020 Jun 8;21(1):498. doi: 10.1186/s13063-020-04421-z.
4
Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.无症状、轻度和重症有症状 SARS-CoV-2 感染患者的病毒载量、淋巴细胞亚群和细胞因子:一项回顾性研究。
Virol J. 2021 Jun 12;18(1):126. doi: 10.1186/s12985-021-01597-x.
5
Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients: Clinical and laboratory characteristics.伊朗 COVID-19 患者外周血淋巴细胞的凋亡和免疫表型:临床和实验室特征。
J Med Virol. 2021 Mar;93(3):1589-1598. doi: 10.1002/jmv.26505. Epub 2020 Sep 28.
6
SARS-CoV-2-reactive interferon-γ-producing CD8+ T cells in patients hospitalized with coronavirus disease 2019.COVID-19 住院患者中针对 SARS-CoV-2 的干扰素-γ产生的 CD8+ T 细胞。
J Med Virol. 2021 Jan;93(1):375-382. doi: 10.1002/jmv.26213. Epub 2020 Jul 2.
7
Peripheral blood CD4+ cell counts but not CD3+ and CD8+ cell counts are reduced in SARS-CoV-2 infection.外周血 CD4+ 细胞计数降低,但 CD3+ 和 CD8+ 细胞计数无变化,与 SARS-CoV-2 感染有关。
J Affect Disord. 2020 Dec 1;277:375-378. doi: 10.1016/j.jad.2020.08.037. Epub 2020 Aug 23.
8
Fine Analysis of Lymphocyte Subpopulations in SARS-CoV-2 Infected Patients: Differential Profiling of Patients With Severe Outcome.严重 SARS-CoV-2 感染患者淋巴细胞亚群的精细分析:严重结局患者的差异特征分析。
Front Immunol. 2022 Jul 15;13:889813. doi: 10.3389/fimmu.2022.889813. eCollection 2022.
9
IFN-γ cell response and IFN-γ release concordance after in vitro SARS-CoV-2 stimulation.体外 SARS-CoV-2 刺激后 IFN-γ 细胞反应和 IFN-γ 释放的一致性。
Eur J Clin Invest. 2021 Dec;51(12):e13636. doi: 10.1111/eci.13636. Epub 2021 Jun 24.
10
Immune Cells Profiles In The Peripheral Blood Of Patients With Moderate To Severe COVID-19 And Healthy Subjects With and Without Vaccination With The Pfizer-BioNTech mRNA Vaccine.免疫细胞谱在中度至重度 COVID-19 患者的外周血中以及健康人群中的表现,这些健康人群有无接种辉瑞-生物科技公司的 mRNA 疫苗。
Front Immunol. 2022 Jul 11;13:851765. doi: 10.3389/fimmu.2022.851765. eCollection 2022.

本文引用的文献

1
Induction of Humoral and Cellular Immunity by Intradermal Delivery of SARS-CoV-2 Nucleocapsid Protein Using Dissolvable Microneedles.采用可溶性微针经皮递呈 SARS-CoV-2 核衣壳蛋白诱导体液和细胞免疫
J Immunol Res. 2021 May 17;2021:5531220. doi: 10.1155/2021/5531220. eCollection 2021.
2
Peripheral and lung resident memory T cell responses against SARS-CoV-2.外周和肺部驻留记忆 T 细胞对 SARS-CoV-2 的反应。
Nat Commun. 2021 May 21;12(1):3010. doi: 10.1038/s41467-021-23333-3.
3
Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to animals: an updated review.动物中严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的传播:最新综述。
J Transl Med. 2020 Sep 21;18(1):358. doi: 10.1186/s12967-020-02534-2.
4
Characteristics and reference ranges of CD4T cell subpopulations among healthy adult Han Chinese in Shanxi Province, North China.中国北方山西省健康成年汉族人 CD4+T 细胞亚群的特征和参考范围。
BMC Immunol. 2020 Aug 3;21(1):44. doi: 10.1186/s12865-020-00374-9.
5
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.COVID-19 疾病患者和未接触者体内针对 SARS-CoV-2 冠状病毒的 T 细胞反应的靶标。
Cell. 2020 Jun 25;181(7):1489-1501.e15. doi: 10.1016/j.cell.2020.05.015. Epub 2020 May 20.
6
Do pets protect their owners in the COVID-19 era?在新冠疫情时代,宠物会保护它们的主人吗?
Med Hypotheses. 2020 Sep;142:109831. doi: 10.1016/j.mehy.2020.109831. Epub 2020 May 12.
7
Potential infectious risk from the pets carrying SARS-CoV-2.携带新型冠状病毒的宠物带来的潜在感染风险。
Travel Med Infect Dis. 2020 May-Jun;35:101737. doi: 10.1016/j.tmaid.2020.101737. Epub 2020 May 5.
8
Molecular basis of COVID-19 relationships in different species: a one health perspective.COVID-19 在不同物种间关系的分子基础:一种大健康视角。
Microbes Infect. 2020 May-Jun;22(4-5):218-220. doi: 10.1016/j.micinf.2020.03.002. Epub 2020 Mar 17.
9
Emerging coronaviruses: Genome structure, replication, and pathogenesis.新兴冠状病毒:基因组结构、复制和发病机制。
J Med Virol. 2020 Apr;92(4):418-423. doi: 10.1002/jmv.25681. Epub 2020 Feb 7.
10
Establishment of normative ranges of the healthy human immune system with comprehensive polychromatic flow cytometry profiling.建立健康人类免疫系统的规范范围,采用全面多色流式细胞术分析。
PLoS One. 2019 Dec 11;14(12):e0225512. doi: 10.1371/journal.pone.0225512. eCollection 2019.